Literature DB >> 6958899

Noncontraceptive estrogen use and the occurrence of ovarian cancer.

C La Vecchia, A Liberati, S Franceschi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6958899

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

Review 1.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 2.  [The role of progestins].

Authors:  H I Wyss
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 3.  That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.

Authors:  T G Palferman
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

4.  The aftermath of Angie's overdose: is soap (opera) damaging to your health?

Authors:  S Platt
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-11

5.  Hormone replacement therapy and survival after surgery for ovarian cancer.

Authors:  R A Eeles; S Tan; E Wiltshaw; I Fryatt; R P A'Hern; J H Shepherd; C L Harmer; P R Blake; C E Chilvers
Journal:  BMJ       Date:  1991-02-02

6.  Hormone replacement therapy and risk of epithelial ovarian cancer.

Authors:  D M Purdie; C J Bain; V Siskind; P Russell; N F Hacker; B G Ward; M A Quinn; A C Green
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.